We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

A picture of Molly Campbell

Molly Campbell profile page

Senior Science Writer

In the editorial team Molly reports on a broad range of scientific topics, covering the latest breaking news and writing long-form pieces for The Scientific Observer. She is a fervent believer that science – and science communications – should be accessible to everyone. In 2020, she created the Teach Me in 10 video series, where weekly guests discuss and teach a scientific concept in less than 10 minutes. Prior to joining Technology Networks in 2019, Molly worked as a clinical research associate in the NHS and as a freelance science writer. She has a first-class honors degree in neuroscience from the University of Leeds and received a Partnership Award for her efforts in science communication.

Got a Question for Molly Campbell?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 866

In the “Nick” of Time: Researchers Identify a Surprising Behaviour of CRISPR Nucleases

In a recent academic collaboration, scientists discovered another surprising behavior of the Cas9 and Cpf1 enzymes – a behavior which may have implications when developing novel therapies with CRISPR. We spoke with Brett Robb, the Scientific Director for RNA and Genome Editing at New England Biolabs Inc, and Becky Fu (previously a graduate student at Stanford University and now a Postdoctoral fellow at UCSF) to learn more about their research.
Industry Insight

DNA and RNA: Why It’s All About Integrity

In this interview, we spoke with Knut Wintergerst, PhD, General Manager of Biomolecular Systems and Solutions (BSS) and Diagnostics and Genomics Group (DGG) at Agilent to learn more about why DNA and RNA sample integrity is important to scientists and how it can be maintained and analyzed.

Researchers Use Cigarette Cropland to Grow Medical and Industrial Proteins

Scientists have successfully reared genetically engineered tobacco plants to produce medical and industrial proteins outdoors in the field.

Drop-seq Applied Successfully in Plant Cells for the First Time

An open-source RNA analysis platform, Drop-seq, has recently been applied successfully in plant cells for the first time. We spoke with Christine Shulse, PhD, from the DOE Joint Genome Institute to learn more about this innovative breakthrough and its potential applications.
A Novel Application for Atom Probe Tomography: Deciphering Protein Structure content piece image

A Novel Application for Atom Probe Tomography: Deciphering Protein Structure

Researchers at Chalmers University of Technology have, for the first time, utilized Atom Probe Tomography to study protein structure. Here, we speak with Martin Anderrson to learn more about this method and how it may impact the future of proteomics and drug discovery.
BioAccord LC-MS: Making Mass Spectrometry Available to the Masses content piece image
Industry Insight

BioAccord LC-MS: Making Mass Spectrometry Available to the Masses

Earlier in 2019, Waters Corporation announced their BioAccord LC-MS System for biopharmaceutical analysis. We spoke with John Gebler, PhD, Director of Strategic Business Development at Waters Corporation to learn more about the BioAccord System and its applications.
Neurogenomics content piece image


Over the recent decades, science has witnessed the coupling of the neuroscience and genomics research fields to create a novel area known as neurogenomics. In this infographic, we explore how neurogenomics came to be, the methodologies commonly adopted in research studies and how it contributes to our understanding of neurological diseases.
Meet Josiah Zayner, the Biohacker Next Door content piece image

Meet Josiah Zayner, the Biohacker Next Door

Josiah Zayner, PhD, is considered by many as fairly "unconventional" in his scientific practice as a biohacker. In this interview, we discuss the aims of a biohacker and some of his previous experiments, including injecting himself with CRISPR gene-editing technology in front of a live audience.
Biologist Plans to Make More CRISPR-edited Babies – “I Think I’m Crazy Enough to Do It” content piece image

Biologist Plans to Make More CRISPR-edited Babies – “I Think I’m Crazy Enough to Do It”

An article published in Nature outlines the intentions of Denis Rebrikov, a molecular biologist from Russia, to produce gene-edited babies, making him the "second" Jiankui He.
The Evolution of Proteomics - Professor John Yates content piece image

The Evolution of Proteomics - Professor John Yates

The final instalment of The Evolution of Proteomics series features an interview with Professor John Yates from the Department of Molecular Medicine at Scripps Research. The Yates laboratory is focused on developing strategies and tools in proteomics to answer basic biological questions.